Response to PARPis in different BRCA1/2-associated cancers varies widely, and BRCA1/2-mutations are not synonymous with HRR deficiency, as other secondary somatic mutations may restore or bypass BRCA function [56,57]. The gene discussed is BRCA1; the disease is cancer.